Evidence mapPaperPMID 39967741Full record

ArticleAccess microbiology2025

The ratio between SARS-CoV-2 RNA viral load and culturable viral titre differs depending on the stage of infection: a case study of household transmission in an adult male.

Michael K Porter, Alexander Viloria Winnett, Linhui Hao, Natasha Shelby, Jessica A Reyes, Noah W Schlenker, Anne E Romano, Colton Tognazzini, Matthew Feaster, Ying-Ying Goh and 2 more

Abstract readCase Reports
In one paragraph

Article in Access microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Michael K PorterDivision of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA 91125, USA.ORCID 0000-0002-0777-7563
Alexander Viloria WinnettDivision of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA 91125, USA.ORCID 0000-0002-7338-5605
Linhui HaoDepartment of Immunology, University of Washington, Seattle, WA 98109, USA.ORCID 0000-0002-7325-1009
Natasha ShelbyDivision of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA 91125, USA.ORCID 0000-0001-9097-3663
Jessica A ReyesDivision of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA 91125, USA.ORCID 0000-0002-5507-7633
Noah W SchlenkerDivision of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA 91125, USA.ORCID 0000-0002-8581-4403
Anne E RomanoDivision of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA 91125, USA.
Colton TognazziniPasadena Public Health Department, Pasadena, CA 91125, USA.ORCID 0000-0002-2754-3588
Matthew FeasterPasadena Public Health Department, Pasadena, CA 91125, USA.ORCID 0000-0001-9966-2845
Ying-Ying GohPasadena Public Health Department, Pasadena, CA 91125, USA.ORCID 0000-0001-5136-7214
Michael GaleDepartment of Immunology, University of Washington, Seattle, WA 98109, USA.ORCID 0000-0002-6332-7436
Rustem F IsmagilovDivision of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA 91125, USA.ORCID 0000-0002-3680-4399

Funding

University of Washington Arboviral Research Network (UWARN)U01AI151698 · NIAID · UNIVERSITY OF WASHINGTON · PI GALE, MICHAEL, RABINOWITZ, PETER MACGARR · 2020 to 2024
$11.4M
Longitudinal mucosal immune response to SARS-CoV-2 starting prior to infectionF30AI167524 · NIAID · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI VILORIA WINNETT, ALEXANDER · 2022 to 2024
$127k
Gates Foundation INV-023124NIAID NIH HHS F30 AI167524NIAID NIH HHS U01 AI151698
6 · The paper itself

Abstract

Effective public health measures for communicable diseases rely on the ability to identify infectious individuals and prevent transmission from those individuals. For severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the presence of replication-competent virus in specimens from an individual is the gold standard for confirming infectiousness. However, viral culture from clinical specimens is difficult and infrequently performed. Instead, infectiousness may be inferred based on the abundance of viral RNA (or viral load) in a specimen, which is more easily assessed. For this reason, understanding the relationship between RNA viral load and infectious viral titre has important implications for public health strategy. In this case report, we quantified incident, longitudinal SARS-CoV-2 viral loads collected from saliva and nasal-swab specimens, and viral titre from nasal-swab specimens. We observed that the relationship between viral load and viral titre decreases by over five orders of magnitude throughout the course of the infection. Our work demonstrates the potential for infectious virus even in specimens with low viral loads collected during the early phases of infection.

Indexed as

cultureincidentinfectivitylongitudinalSARS-CoV-2

Identifiers

PMID39967741
PMCPMC11833051

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.